In addition, we demonstrated nesfatin-1/NUCB-2 enhanced migration, invasion and mesenchymal phenotype in colon cancer through LKB1/AMPK/TORC1/ZEB1 pathways (Figure 9C). Here, NUCB2 is linked to malignant colon neoplasm.